| OA02.02 | Correlates of high HIV transmission areas in a generalized hyperendemic setting: findings from a national survey in Eswatini | Oral Abstract Session | Treatment as prevention |
| OA02.03 | Progress toward HIV elimination goals: trends in and projections of treatment as prevention strategy in 38 African countries | Oral Abstract Session | Treatment as prevention |
| PE29.01 | CCR5 antibody blockade protects rhesus macaques from rectal SHIV acquisition | E-poster | Treatment as prevention |
| PU29.01 | Programming for female sex workers during COVID-19 pandemic: experiences from Bar Hostess Empowerment and Support Program, Nairobi Kenya | Publication Only | Treatment as prevention |
| OA02.05LB | Risk factors for HIV transmission in heterosexual men, men who have sex with men, and transgender women participating in the HVTN 702 'Uhambo' and HVTN 503/503-S 'Phambili' HIV vaccine trials | Oral Abstract Session | Transmission of HIV |
| OA22.01 | R5 tropic HIV-1 is preferentially translocated of across genital mucosa while X4 tropic HIV-1 is selectively sequestered in genital epithelial cells and activates type I IFN signaling | Oral Abstract Session | Transmission of HIV |
| PE28.01 | An analysis of gender-based violence and HIV risk among adolescents and youth across 10 countries | E-poster | Transmission of HIV |
| PE28.02 | Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in China | E-poster | Transmission of HIV |
| PE28.03 | Site-level prevalence of gonorrhea and chlamydia is correlated with site-level HIV incidence in African women seeking contraception | E-poster | Transmission of HIV |
| PE28.04 | Circulating South African transmitted/founder HIV-1 subtype C uses CCR5 and not CXCR4 or CCR3 for cell entry | E-poster | Transmission of HIV |